Furthermore, we did not study cardiometabolic risk biomarkers, such as hs-CRP, which were shown to be elevated in adults and women post-GDM with MetS [18,21,66,67], or adiponectin, which was reduced in MetS [67,68]. This evidence concerns the gene ADIPOQ and metabolic syndrome.